Vitamin D in Osteosarcopenic Obesity [PDF]
Nutrients, 2022 Osteosarcopenic obesity is a unique clinical condition where low bone and muscle mass coexist in individuals with obesity. Alterations in adipose tissue, skeletal muscle and bone are strictly interconnected, and vitamin D plays key roles in several metabolic pathways that are involved in maintaining musculoskeletal health and glucose homeostasis.
Andrea Giustina +2 more
exaly +5 more sources
Osteosarcopenic Visceral Obesity and Osteosarcopenic Subcutaneous Obesity, Two New Phenotypes of Sarcopenia: Prevalence, Metabolic Profile, and Risk Factors [PDF]
Journal of Aging Research, 2018 Background. The main criticism of the definition of “osteosarcopenic obesity” (OSO) is the lack of division between subcutaneous and visceral fat.
Simone Perna +5 more
doaj +8 more sources
Osteosarcopenic Obesity: Current Knowledge, Revised Identification Criteria and Treatment Principles [PDF]
Nutrients, 2019 Osteosarcopenic obesity (OSO) syndrome describes the simultaneous deterioration of bone, muscle and excess fat, resulting in reduced functionality and systemic metabolic dysregulation. The key component contributing to this may be ectopic fat in the viscera, bone and muscle.
Owen J Kelly +2 more
exaly +6 more sources
Sex-Specific Associations between Serum Ferritin and Osteosarcopenic Obesity in Adults Aged over 50 Years [PDF]
Nutrients, 2022 We investigated the sex-specific association between ferritin and adverse body composition in adults aged over 50 years in a population-based cohort.
Yong-Taek Lee +2 more
exaly +3 more sources
The Cooccurrence of Obesity, Osteoporosis, and Sarcopenia in the Ovariectomized Rat: A Study for Modeling Osteosarcopenic Obesity in Rodents [PDF]
Journal of Aging Research, 2017 Background. Obesity, osteoporosis, and sarcopenia may individually occur due to age-related gradual alterations in body composition. This study investigates the cooccurrence of these age-related diseases in female animals with low levels of ovarian ...
Zahra Ezzat-Zadeh +3 more
doaj +4 more sources
Osteosarcopenic obesity: the role of bone, muscle, and fat on health. [PDF]
J Cachexia Sarcopenia Muscle, 2014 Osteopenia/osteoporosis, sarcopenia, and obesity are commonly observed in the process of aging, and recent evidence suggests a potential interconnection of these syndromes with common pathophysiology. The term osteosarcopenic obesity has been coined to describe the concurrent appearance of obesity in individuals with low bone and muscle mass.
Ormsbee MJ +6 more
europepmc +7 more sources
Laboratory markers of osteosarcopenic obesity
Российский кардиологический журнал, 2023 Osteosarcopenic obesity syndrome involves the simultaneous deterioration of bone, muscle, and excess fat accumulation, resulting in systemic metabolic dysregulation.
O. V. Gritsenko +3 more
doaj +2 more sources
Is There Enough Evidence for Osteosarcopenic Obesity as a Distinct Entity? A Critical Literature Review [PDF]
Calcified Tissue International, 2019 The co-existence of impaired bone health (osteopenia/osteoporosis), reduced muscle mass and strength (sarcopenia), and increased adiposity (obesity) in middle-aged and older people has been identified in recent studies, leading to a proposal for the existence of "osteosarcopenic obesity" as a distinct entity. Evidence for the pathophysiological overlap
Bauer, Jürgen +23 more
core +12 more sources
Association of serum vitamin D with osteosarcopenic obesity: Korea National Health and Nutrition Examination Survey 2008–2010 [PDF]
Journal of Cachexia, Sarcopenia and Muscle, 2017 BACKGROUND: Serum vitamin D levels have been reported to be associated with individual components of body composition. However, the relationship between serum vitamin D and combined indices of adverse body composition is largely unknown.
Yunhwan Lee, Okhee Lee, Yoon-Sok Chung
exaly +4 more sources
Osteosarcopenic obesity in cardiovascular patients. Controversial and open issues
Кардиоваскулярная терапия и профилактика, 2021 See “Inflammaging in the pathogenesis of chronic non-communicable diseases”, Kim O. T. in Opinion of invited editor, pp. 54-55.The study of osteosarcopenic obesity (OSO) in patients with cardiovascular diseases (CVDs) in recent years has caused a dis ...
K. E. Krivoshapova +3 more
doaj +3 more sources